glabridin has been researched along with wighteone in 2 studies
| Studies (glabridin) | Trials (glabridin) | Recent Studies (post-2010) (glabridin) | Studies (wighteone) | Trials (wighteone) | Recent Studies (post-2010) (wighteone) |
|---|---|---|---|---|---|
| 172 | 4 | 122 | 10 | 0 | 5 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kuang, Y; Li, K; Lin, Y; Qiao, X; Sabir, G; Song, W; Wang, S; Ye, M | 1 |
| Chen, K; Ji, S; Kuang, Y; Li, K; Lin, Y; Qiao, X; Song, W; Wang, S; Ye, M | 1 |
2 other study(ies) available for glabridin and wighteone
| Article | Year |
|---|---|
Screening for bioactive natural products from a 67-compound library of Glycyrrhiza inflata.
Topics: Animals; Anti-Inflammatory Agents; Apoptosis; Biological Products; Cell Line, Tumor; Drug Screening Assays, Antitumor; Glycyrrhiza; HEK293 Cells; Hep G2 Cells; Humans; Lipopolysaccharides; Macrophages; MCF-7 Cells; Mice; Monophenol Monooxygenase; NF-kappa B; Plant Roots; Protein Tyrosine Phosphatase, Non-Receptor Type 1; RAW 264.7 Cells; Small Molecule Libraries | 2017 |
Nrf2 activators from Glycyrrhiza inflata and their hepatoprotective activities against CCl
Topics: Administration, Oral; Animals; Carbon Tetrachloride; Cell Survival; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Dose-Response Relationship, Drug; Glycyrrhiza; Hep G2 Cells; Humans; Male; Mice; Mice, Inbred ICR; Molecular Structure; NF-E2-Related Factor 2; Plant Extracts; Plant Roots; Rats; Rats, Sprague-Dawley | 2017 |